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Res~J1~: For I:~phas~c shocks OFT wa~ Iowest tor a total shock D of 12 
ms (P ~ 0003, ANOVA) whereaa for trlphas=c Ahocks OFT wa~ Iowest for a 
total shock D 0t 10 ms (P ~ O001, ANOVA). The b~phas¢ OFT at 12 ms was 




DFT mn~ma at ~eent  ~ ~~ At ol~n~zed s~k D the OFT is 
~r~'y  ~ tee ~ man to« tnphas~ st~:ks. 
11;00 
~ ~ t  Biphasi¢ Verùus ~ ~ k ~  Wavefom~ 
Efficacy kt ~ l m r  ~ of Longef 
~ra l ions  
Y Yamanouc~~ J,E Bm~ee, K.A Mo~wey. D.G. H~l~s, A_M. Do~ohoo, 
B-L W~olto PJ. Tcttou, ~ ~ Fot~'~~a~oß C/m~tand. OH. 
Ver~-V~ ~~~a~on ~1~) dura~n ha.s be~ n~m~ed ~o a l f i~  energy re- 
q~~~e~t tor def~~ffatmn. W~e ~ wavetom~s ha~e Iower def~~la- 
bon thmsho~l I~,an ~ ones ~~'~ VF o~ amund 10 sec, we ~~~'ted 
the t~ypott~s~ that ~ sttoOks are P.,,,,,,,,~~ effec~~ than monophas~c 
w~vefom~ eren with rongm VF durat~~ su~as  I mm_ 
Afeff~ods: In a swme moßtel at e~temal defibetPtalion (n = 12, 35 ± 6 kg), 
we d e ~  ff~e sto~ed enen~ at 50% deftl~~~atmn s~ccess (ES0) to~ VF 
O! 10 sec and 1 m~ d~a~o~s. A ~ (M: O(Oi«E 70~= tJR) and two 
b/phase wavetomts (~t:  6G~O-~,F, 70% ~Itr3 ms pu~se widffl; B2: 60/20-ùF, 
7(T~o !~3 ms ~ wk:~) wem tested. E50 was measwed by a Bayesmn 
esl~ma~n tec.'-~que w~ each ~a~~orm and each VF dura~on~ 
Resu#s: ESO (joutes) am shown m t~e ta~~e be~~w 
k~~=rn:s VF @ I>vaf,,~ 
10~~c I m,n 
~,~ 131 = 41 114 = 62 O ~  
Bi 57 = 18 77 .- 45 0 1954 
B,?. ~0 : :~6 72 : ~~3 0 66E0 
p-'~a~ue O 000"~ 0 C~344 
~us~o.~s :  1) ESO d~d not increase at VF dura f~ o! up tO t rt~m ~~gar0. 
less of shock waveform. 2) Extemal biphaS~c shod~ were more effectwe 
than monophas¢ wavetorms et, en with VF ot tonger duta~ 
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~6-~ Prospective Randomized Comparison of 50B0% 
Vemus 65/6P/0 Tilt Biphaslc Wavefomt on Intemal 
Defibdllaflon in Humans 
MO. Sweeney, A. Natate, K.J. Verein, C.D. Swerdlow, JH. Baker, 
PJ. OeGroot. Brigham and Women~ Ho~ital. B~sfOn. MA. Medtron~c. fnc . 
Minneapo/is, MN. USA 
The optimal biphasic wavetorm bit for defibntlatmn is unknown and may vary 
with electrode configuration and capacitance. In 60 patients underg~ng ICD 
implantatton wdh an identical etectrode configurat~on and an extema] car- 
dioverter/c~efibril]ator with 110-uF capacitance, defibnl)ation threshold (,DFT) 
metrics wem determined for 50/50% versus 65/65% tut biphasic wavetorms. 
Phase l/phase 2 ti[ts wem identical, and phase 2 leading edge voltage 
equaled phase 1 trailing edge voltage. The electrode configu~tion used a 
RV coil as cathode ( - )  and a left pectorai active can emulator (CAN) plus a 
SVC coil as anode (+). Energy thresholds wem rneasured in random order in 
each patient using a log linear binary search method. Results wem anahjzed 
with paired t-tests. 
DFT metr~c 50/50% titt 65/65% tilt .~(%) p 
Stored ener~jy. J 9.~ ± 5.7 10.8 ± 6.4 16 0.007 
Delivered energy. J 8.6 ± 5.4 10.6 ± 6.3 19 0.001 
Voltage. V 391 ± 11B 424 ± 128 8 0.004 
Currenl, A 10.9 + 40 12.0 ~ 4.4 9 0.002 
Resistance. ~ 36.9 ± 7.6 36.6 ~ 7.4 1 0.160 
Corg~s~~n: Fo~ a RV (-)/(::AN - SVC («) eled~(Le conf~mt~on 
110,~ capacitark~e, a ~~o tdt b~has~c w=veform msu~ts ~n s@~'~y 
lowef currem, vott~Oe ano energy det~orittatm~ ~«esho~~ ve~s~ a 8~% 
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Howev~, patent ~ ol at~tal ~ ~ o~ wave~om~ 
~ms~ m ~ IL411/~V ~ as 8 lun~ton Of ~ ~ m a 
pre~n'mae/~ ~ tm me ~eae. 
~ :  A 3 ~ ~ ~ eleetmele ~ ove~ ~he ~ ~ en 
t~~e lateral ~ Ot ihe ~ foot a f~ ~ ~ c~a ~ caH ~ v~re 
wa~e.*orms were ~ to I~~e an equal ¢ ; -~~ ra~ belween pheses I 
ar~ 2 a~lme same phase ~ (iS.5 ms/~.5 ms). ~ ~ 
were ~ n e d  usmg a 3 pomt up/down aplPrOa~ and defmed as the 
avetage cuwem Ovef the ~me coume o! tt~ w ~ .  
~ ~~~=a~m  re~au~ m m~mg~a~ eq~~a=c 
A 22 .6  ± 5.6% (p < 0.0005) venmsC 
B 45-3 ~: A5% (~ < O.OOß~5) ~ C 
~ :  The sema~n mmsho~s tor m~ ~ r  I~phas~cs (mean 
2 15 ± 0.7"3 mA) wem consmtently (32/32) the h~hest Thm waveinrrn coum 
be descnt~l as o~e of e~dmmely low tllL 
Conc~us~~n- These res~s suggest mat tor equat ~lverod charge a 
rectang~ar wav~u,ù, tms em h~ghest ~ ~ ~  Ong~ng wo~k m 
evaluatmg each wavotonWs atr~~ derd=rtllatmn effmaw. 
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[ -8 -~ Eff~¢t of Secofld Phase Duration on Biphasic 
Def ibdùa~n Etfi¢acy in Humans 
B Me~ely, A_ LuJ:~~ki', 1: Gyõngy. E Lew¢ka-Nowak I , F Horkay, 
G. Sw~atecka'. L GeùC, E Berief, J Pilz ~. M Schaldach ~ . Semn~h~els 
A'~=,~~al Urm~rs~. B~fapest, Hu~jar~, ' Med/cal Unn~rstty et Gdarrsk, 
~Fr~=oYrch-Atexar~er  of N ~ ,  Gem~~y 
The morgt~logy of the I~phas¢ puP3e torm m known m influence defilonllatvon 
eff~cao/. However, file ~0t~ma! ~ wavetorrn for second phase aurä~c~ 
~ ;Tlan USm¢J a ~ r  OUtl~Ut c/lpaeitof has not yet been deflfle¢L Ins  
mù~~~r~e~, ~ and ~o=~ct~ study, me defi~~~on elr¢acy of 
2 m~ec ~s. 5 msec s«~d i~ase d~~on of ~q~mc i~ses us~g 100 
ùF ~ was co~pared ffi 27 pafle~s (at;e: 56 + 13 ye, ars, m~l~: 
81%. CAD: 66%. DCM: 15%, EF: 43 ± 15%, ~~l~od~rom~: 55%) ~ a 
uni~~ar pectoral trans~anous det~0d¢~on system (RV-E us. can; fracla~ 
coated SPS-~ead ~,  Pt~ax 06 ac~;~e hoü~~-,0, l~otronCk). The first phase 
parametem tor Oafft ~~,a=~ wavefa~ms ~ as to~sws: d~trge~ ~a~~ge 
~ 0(~o, switct~ng va~ge 40%. Deftl~Pù~,an threShoM (DFT) wes det~mm~l 
~ 1 r'~dom orc~er wtth eitt~, 2 ~~~~c er 5 ,~-,süc second phase tesled first 
usmg a b~ary search protocol durtng ICD n'nplantatton. The fo tk~ data 
wem obtaineO at DFT (mean ± SD): 
2. ~ phase Chargn~,~Mage .. S~ored Gn¢h"gy .(~tiven~ ermrgy 
2 mse¢ 42~B ± 116 V 9,8 ~: 5.1 J 6.5 + 4.4 
5msec 446 ± 116V 108 ¢ 53J 99 ± 4.9 
p~ p = 0044 p =0065 p =0005 __ 
Significant difference was found in chargmg voltsge and delB, ered energy 
at DFT between 2. rnsec and 5 msec 2 ~ 10hase dursl'~on pu~se tern1 usin¢ 3
100 ~,F c~q~acitance. Compared to 5 ms 2 ~ phase, 12 pattents had a DFT 
decrease w~th 2 ms 2 ~ phase durat~on and 3 pts had a DFT ir¢re~;e ~ 2 
ms; in the remainder, there was no difference. The mean shock t~~,~Fù;e 
was 65,8 ~ 7.3 ~ respecthrely. 
In conctus~on, reduction in second pulse ware duration seerns to sli~~tly 
imp¢ove overall defibnllation efficacy in humans. 
